Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Interest & Investment Income (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Interest & Investment Income for 8 consecutive years, with $6.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest & Investment Income fell 36.69% year-over-year to $6.7 million, compared with a TTM value of $32.9 million through Sep 2025, up 8.7%, and an annual FY2024 reading of $34.3 million, up 144.85% over the prior year.
  • Interest & Investment Income was $6.7 million for Q3 2025 at Bicycle Therapeutics, down from $7.5 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $10.6 million in Q3 2024 and bottomed at $15000.0 in Q1 2021.
  • Average Interest & Investment Income over 5 years is $4.0 million, with a median of $2.9 million recorded in 2023.
  • The sharpest move saw Interest & Investment Income tumbled 93.8% in 2021, then surged 8195.83% in 2022.
  • Year by year, Interest & Investment Income stood at $58000.0 in 2021, then soared by 4450.0% to $2.6 million in 2022, then surged by 137.82% to $6.3 million in 2023, then skyrocketed by 64.17% to $10.3 million in 2024, then tumbled by 34.97% to $6.7 million in 2025.
  • Business Quant data shows Interest & Investment Income for BCYC at $6.7 million in Q3 2025, $7.5 million in Q2 2025, and $8.4 million in Q1 2025.